Bortezomib plus <scp>EPOCH</scp> is effective as frontline treatment in patients with plasmablastic lymphomaJorge J. Castillo, Michele Bibas, Guillaume Cartron et al.|British Journal of Haematology|2018Cited by 90
Bortezomib plus EPOCH is effective as frontline treatment in patients with plasmablastic lymphomaJorge J. Castillo, Michele Bibas, Thomas A. Guerrero-Garcia et al.|USMP Repository (Universidad de San Martín de Porres)|2019Cited by 13